Are older antipsychotic drugs obsolete? (Q42412715)

30 October 2017

Are older antipsychotic drugs obsolete? (English)

1 reference

30 October 2017

Rohan Ganguli

1

1 reference

PMCID

1476714

30 October 2017

Martin Strassnig

series ordinal

2

1 reference

PMCID

1476714

30 October 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

30 October 2017

1 reference

30 October 2017

332

1 reference

30 October 2017

7554

1 reference

30 October 2017

1346-1347

1 reference

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

30 October 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

28 May 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

30 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

A meta-analysis of the efficacy of second-generation antipsychotics

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1476714

Practical treatment information for schizophrenia

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16763227

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.332.7554.1346

1 reference

30 October 2017

1 reference

30 October 2017

1 reference

PMCID

1476714